Wyeth Fosamax Co-Promotion Deal With Merck Ends Jan. 1

 
• By The Pink Sheet

Wyeth-Ayerst's co-promotion of Merck's osteoporosis therapy Fosamax will end Jan. 1.

More from Archive

More from Pink Sheet